We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
+$250M
Cap. Flow
-$95M
Cap. Flow %
-1.49%
Top 10 Hldgs %
24.3%
Holding
176
New
25
Increased
62
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$45.6M
2
ROL icon
Rollins
ROL
+$37.7M
3
CPRT icon
Copart
CPRT
+$36.7M
4
MDB icon
MongoDB
MDB
+$36.7M
5
TTD icon
Trade Desk
TTD
+$36.6M

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$76.4M
2
PANW icon
Palo Alto Networks
PANW
+$64.1M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$60.1M
4
LNG icon
Cheniere Energy
LNG
+$51.4M
5
APTV icon
Aptiv
APTV
+$43.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.57%
2 Technology 24.76%
3 Industrials 16.51%
4 Consumer Discretionary 8.57%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSBX
151
DELISTED
Turnstone Biologics
TSBX
$1.2M 0.02%
458,317
-250,000
-35% -$716K
UNP icon
152
Union Pacific
UNP
$172B
$1.02M 0.02%
+4,151
New +$1.02M
OTIS icon
153
Otis Worldwide
OTIS
$27.3B
$1.01M 0.02%
+10,189
New +$942K
NOW icon
154
ServiceNow
NOW
$114B
$1.01M 0.02%
6,600
-3,285
-33% -$498K
KYMR icon
155
Kymera Therapeutics
KYMR
$8.8B
$795K 0.01%
+19,774
New +$708K
EOG icon
156
EOG Resources
EOG
$77.5B
$689K 0.01%
+5,393
New +$630K
LLY icon
157
Eli Lilly
LLY
$1.03T
$680K 0.01%
+874
New +$622K
ACAD icon
158
Acadia Pharmaceuticals
ACAD
$4.55B
– –
-809,391
Closed -$25.3M
ALGN icon
159
Align Technology
ALGN
$12.4B
– –
-1,121
Closed -$307K
AMLX icon
160
Amylyx Pharmaceuticals
AMLX
$2.31B
– –
-1,116,837
Closed -$16.4M
ASND icon
161
Ascendis Pharma A/S
ASND
$16.5B
– –
-180,857
Closed -$22.8M
BEAM icon
162
Beam Therapeutics
BEAM
$2.73B
– –
-261,360
Closed -$7.11M
BILL icon
163
BILL Holdings
BILL
$4.52B
– –
-523,115
Closed -$42.7M
COGT icon
164
Cogent Biosciences
COGT
$7.07B
– –
-2,232,968
Closed -$13.1M
EHC icon
165
Encompass Health
EHC
$11B
– –
-151,644
Closed -$10.1M
EW icon
166
Edwards Lifesciences
EW
$50B
– –
-6,709
Closed -$512K
INCY icon
167
Incyte
INCY
$24.9B
– –
-121,508
Closed -$7.63M
IRWD icon
168
Ironwood Pharmaceuticals
IRWD
$614M
– –
-740,554
Closed -$8.47M
LNG icon
169
Cheniere Energy
LNG
$54.1B
– –
-301,223
Closed -$51.4M
NTLA icon
170
Intellia Therapeutics
NTLA
$1.55B
– –
-372,665
Closed -$11.4M
PRTA icon
171
Prothena Corp
PRTA
$440M
– –
-445,155
Closed -$16.2M
ROIV icon
172
Roivant Sciences
ROIV
$24.8B
– –
-1,143,938
Closed -$12.8M
SHOP icon
173
Shopify
SHOP
$159B
– –
-8,951
Closed -$697K
ZTS icon
174
Zoetis
ZTS
$31.9B
– –
-3,153
Closed -$622K
KRTX
175
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-190,000
Closed -$60.1M
4 5 6
7
8

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Eventide Asset Management held 176 positions worth $6.38B, up 4.1% from $6.13B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2024 filing shows 25 new, 62 increased, 40 reduced and 19 closed positions. Its largest new stake was GitLab: 695,704 shares worth $40.6M. The largest sale was CrowdStrike, an estimated $76.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2024 buy was GitLab: 695,704 shares worth $40.6M.
  • Eventide Asset Management added most to Rollins in Q1 2024, an estimated $37.7M increase.
  • Eventide Asset Management's biggest Q1 2024 reduction was CrowdStrike, cutting an estimated $76.4M.
  • Eventide Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $60.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2024.
  • Eventide Asset Management opened 25 new positions and closed 19 in Q1 2024.
  • Eventide Asset Management's portfolio value rose 4.1% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.